Vexev founders, Dr John Carroll and Dr Eamonn Colley met in Sydney as PhD students interested in fluid dynamics. They have turned their talents to investigate blood flows to try and predict vascular disease.

They have created an ultrasound-powered imaging robot and software platform — to automatically take fast and consistent 3D scans, to supercharge the diagnostic power of vascular clinicians, with the simple push of a button.

The company has secured funding through Blackbird Ventures and are travelling between Australia and the US developing their production prototype and working with dialysis patients and clinicians to refine their technology.